Abstract 96: Integrated molecular analysis of human dedifferentiated liposarcoma identifies a population of liposarcoma progenitors vulnerable to TGF beta inhibition
Nadège Gruel(Inserm), Sarah Watson(Centre National de la Recherche Scientifique), Julien Vibert(Inserm), Olivier Delattre(Institut Curie), Sylvie Bonvalot(Dana-Farber Cancer Institute), Odette Mariani(Institut Curie), Sophie El Zein(Institut Curie), Chloé Quignot(Université Sorbonne Nouvelle), Dimitri Tzanis(Université Paris Cité), Sylvain Baulande, Joshua J. Waterfall(National Cancer Institute)
Cited by 2
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
The Life History of 21 Breast Cancers
|Cell|2012|1.5k